- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.07. | Flashpoint Therapeutics Appoints Barry Labinger as CEO | ||
| 29.07. | Asahi Kasei Life Science to Build New Spinning Plant for Virus Removal Filters | ||
| 29.07. | Novo Nordisk Appoints New President & CEO | ||
| 29.07. | ViroCell Biologics Delivers Novel Retroviral Vector to AvenCell Therapeutics for Allogeneic CAR-T Therapy | ||
| 28.07. | Boehringer Ingelheim and Re-Vana Therapeutics Partner on Long-Acting Ophthalmics | ||
| 28.07. | GSK, Hengrui Sign $500M Drug Development Pact | ||
| 28.07. | Veranova Appoints Thomas Rohrer VP of Bioconjugation | ||
| 28.07. | Pistoia Alliance Launches New Initiatives to Enhance Pharmacovigilance | ||
| 28.07. | CS Analytical Launches Gas Testing Analytical | ||
| 28.07. | Lilly Acquires Verve Therapeutics | ||
| 28.07. | ReAlta Life Sciences Names Ellen Lubman as Chief Business Officer | ||
| 28.07. | MAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine | ||
| 28.07. | AstraZeneca's sBLA for IMFINZI Accepted and Granted Priority Review | ||
| 25.07. | Simtra Purchases 65-Acre Property in Indiana | ||
| 25.07. | Sanofi's Sarclisa Gains EU Approval for Multiple Myeloma | ||
| 25.07. | Bristol Myers Squibb Names New EVP, Chief Medical Officer and Head of Development | ||
| 24.07. | Matchpoint Therapeutics, Novartis Partner to Develop Covalent Medicines for Inflammatory Diseases | ||
| 24.07. | Verastem Oncology's VS-7375 Granted Fast Track Designation by the FDA | ||
| 24.07. | Pfizer Bolsters Oncology Pipeline with $1.25B 3SBio Deal | ||
| 23.07. | Stevanato Group Secures $235.4 Million in Financing | ||
| 23.07. | Sygnature Discovery Doubles High-Throughput Chemistry Capacity After Investment | ||
| 23.07. | Crown Bioscience's San Diego Lab Receives CLIA Certification | ||
| 23.07. | Roquette Launches POLYOX Extended Stability Packaging | ||
| 23.07. | Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD | ||
| 23.07. | Ipsen Updates Executive Committee |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .